PHR Insider Trading
Phreesia, Inc. | Services-Business Services, NEC
Comprehensive Trading Performance Summary
The investment history of corporate insiders at Phreesia, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-Business Services, NEC sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2023-12-21 00:14 | 2023-12-19 | Gunzburg Janet | Officer - Principal Accounting Officer | SELL | $23.72 | 118 | $2,799 | 40,579 | -0.3% |
| 2023-12-21 00:13 | 2023-12-18 | Linetsky David | Officer - SVP, Life Sciences | SELL | $23.21 | 259 | $6,011 | 7,573 | -3.3% |
| 2023-11-02 23:39 | 2023-11-01 | Gunzburg Janet | Officer - Principal Accounting Officer | SELL | $13.38 | 298 | $3,988 | 40,697 | -0.7% |
| 2023-10-18 01:22 | 2023-10-16 | Davidoff Michael J. | Officer - SVP, Payer Business | SELL | $16.61 | 1,198 | $19,898 | 92,378 | -1.3% |
| 2023-10-18 01:19 | 2023-10-16 | Gandhi Balaji | Officer - Chief Financial Officer | SELL | $16.61 | 861 | $14,300 | 85,658 | -1.0% |
| 2023-10-18 01:17 | 2023-10-16 | VanDuyn Amy Beth | Officer - SVP, Human Resources | SELL | $16.61 | 665 | $11,045 | 118,146 | -0.6% |
| 2023-10-18 01:15 | 2023-10-16 | Hoffman Allison C | Officer - General Counsel & Secretary | SELL | $16.61 | 1,297 | $21,542 | 115,025 | -1.1% |
| 2023-10-18 01:14 | 2023-10-16 | Roberts Evan | Officer - Chief Operating Officer | SELL | $16.61 | 1,971 | $32,736 | 745,860 | -0.3% |
| 2023-10-18 01:11 | 2023-10-16 | Linetsky David | Officer - SVP, Life Sciences | SELL | $16.61 | 2,078 | $34,514 | 215,036 | -1.0% |
| 2023-10-18 01:08 | 2023-10-16 | Indig Chaim | Director, Officer - Chief Executive Officer | SELL | $16.61 | 3,295 | $54,727 | 1,241,996 | -0.3% |
| 2023-09-20 23:23 | 2023-09-18 | Gunzburg Janet | Officer - Principal Accounting Officer | SELL | $19.79 | 125 | $2,474 | 40,995 | -0.3% |
| 2023-09-20 23:17 | 2023-09-18 | Linetsky David | Officer - SVP, Life Sciences | SELL | $19.67 | 130 | $2,557 | 7,832 | -1.6% |
| 2023-09-15 00:16 | 2023-09-13 | Roberts Evan | Officer - Chief Operating Officer | SELL | $20.34 | 3,907 | $79,465 | 747,831 | -0.5% |
| 2023-09-15 00:14 | 2023-09-13 | Hoffman Allison C | Officer - General Counsel & Secretary | SELL | $20.27 | 5,466 | $110,790 | 116,322 | -4.5% |
| 2023-09-15 00:12 | 2023-09-13 | VanDuyn Amy Beth | Officer - SVP, Human Resources | SELL | $20.24 | 3,826 | $77,455 | 118,811 | -3.1% |
| 2023-09-15 00:09 | 2023-09-13 | Gunzburg Janet | Officer - Principal Accounting Officer | SELL | $20.34 | 934 | $18,996 | 41,120 | -2.2% |
| 2023-09-15 00:08 | 2023-09-13 | Gandhi Balaji | Officer - Chief Financial Officer | SELL | $20.34 | 3,957 | $80,482 | 86,519 | -4.4% |
| 2023-09-15 00:07 | 2023-09-13 | Davidoff Michael J. | Officer - SVP, Payer Business | SELL | $20.26 | 6,559 | $132,880 | 93,576 | -6.6% |
| 2023-09-15 00:06 | 2023-09-13 | Indig Chaim | Director, Officer - Chief Executive Officer | SELL | $20.34 | 6,555 | $133,323 | 1,245,291 | -0.5% |
| 2023-09-15 00:04 | 2023-09-13 | Linetsky David | Officer - SVP, Life Sciences | OPT+S | $20.34 | 2,178 | $44,299 | 7,962 | 0.0% |
| 2023-07-25 23:28 | 2023-07-21 | Davidoff Michael J. | Officer - SVP, Payer Business | SELL | $31.75 | 1,075 | $34,131 | 93,576 | -1.1% |
| 2023-05-11 23:48 | 2023-05-10 | Munson Gillian | Director | SELL | $30.06 | 3,555 | $106,864 | 19,315 | -15.5% |
| 2023-04-26 00:04 | 2023-04-21 | Davidoff Michael J. | Officer - SVP, Payer Business | SELL | $33.13 | 1,075 | $35,615 | 95,773 | -1.1% |
| 2023-04-20 23:15 | 2023-04-18 | Roberts Evan | Officer - Chief Operating Officer | SELL | $32.09 | 7,452 | $239,167 | 716,960 | -1.0% |
| 2023-04-18 23:53 | 2023-04-17 | VanDuyn Amy Beth | Officer - SVP, Human Resources | OPT+S | $31.84 | 570 | $18,149 | 119,435 | 0.0% |
| 2023-04-18 23:53 | 2023-04-17 | Gandhi Balaji | Officer - Chief Financial Officer | SELL | $31.83 | 2,113 | $67,248 | 85,738 | -2.4% |
| 2023-04-18 23:52 | 2023-04-17 | Roberts Evan | Officer - Chief Operating Officer | SELL | $32.01 | 2,600 | $83,229 | 724,412 | -0.4% |
| 2023-04-18 23:52 | 2023-04-14 | Hoffman Allison C | Officer - General Counsel & Secretary | SELL | $31.16 | 3,306 | $103,017 | 128,335 | -2.5% |
| 2023-04-13 23:11 | 2023-04-12 | Roberts Evan | Officer - Chief Operating Officer | SELL | $32.01 | 200 | $6,402 | 728,793 | 0.0% |
| 2023-04-13 00:14 | 2023-04-11 | Davidoff Michael J. | Officer - SVP, Payer Business | SELL | $30.91 | 3,466 | $107,124 | 97,971 | -3.4% |
| 2023-04-05 23:36 | 2023-04-03 | VanDuyn Amy Beth | Officer - SVP, Human Resources | SELL | $30.79 | 2,978 | $91,696 | 96,481 | -3.0% |
| 2023-04-05 23:36 | 2023-04-03 | Smith Mark Douglas | Director | OPT+S | $30.77 | 7,000 | $215,368 | 16,112 | 0.0% |
| 2023-02-07 00:34 | 2023-02-02 | Rasmussen Randy | Officer - Chief Financial Officer | SELL | $40.00 | 4,765 | $190,600 | 145,594 | -3.2% |
| 2023-02-07 00:32 | 2023-02-02 | Linetsky David | Officer - SVP, Life Sciences | SELL | $39.55 | 11,378 | $449,989 | 205,489 | -5.2% |
| 2023-02-07 00:29 | 2023-02-02 | VanDuyn Amy Beth | Officer - SVP, Human Resources | SELL | $40.00 | 300 | $12,000 | 99,459 | -0.3% |
| 2023-02-07 00:22 | 2023-02-02 | Davidoff Michael J. | Officer - SVP, Payer Business | SELL | $39.21 | 7,513 | $294,564 | 97,971 | -7.1% |
| 2023-02-01 03:08 | 2023-01-30 | Davidoff Michael J. | Officer - SVP, Payer Business | OPT+S | $36.29 | 31,820 | $1,154,872 | 105,484 | 0.0% |
| 2023-01-21 00:36 | 2023-01-18 | Hoffman Allison C | Officer - General Counsel & Secretary | SELL | $36.07 | 649 | $23,407 | 129,507 | -0.5% |
| 2023-01-06 00:36 | 2023-01-03 | Roberts Evan | Officer - Chief Operating Officer | SELL | $31.36 | 10,000 | $313,552 | 703,702 | -1.4% |
| 2022-12-22 00:11 | 2022-12-20 | VanDuyn Amy Beth | Officer - SVP, Human Resources | OPT+S | $33.73 | 378 | $12,750 | 87,049 | 0.0% |
| 2022-12-16 00:57 | 2022-12-13 | Hoffman Allison C | Officer - General Counsel & Secretary | SELL | $34.73 | 3,910 | $135,786 | 102,262 | -3.7% |
| 2022-12-16 00:54 | 2022-12-13 | Linetsky David | Officer - SVP, Life Sciences | SELL | $34.61 | 11,377 | $393,755 | 185,485 | -5.8% |
| 2022-12-14 00:30 | 2022-12-09 | Linetsky David | Officer - SVP, Life Sciences | SELL | $29.78 | 26,837 | $799,072 | 196,862 | -12.0% |
| 2022-12-14 00:28 | 2022-12-09 | Rasmussen Randy | Officer - Chief Financial Officer | SELL | $30.97 | 17,329 | $536,764 | 108,539 | -13.8% |
| 2022-11-04 23:11 | 2022-11-02 | VanDuyn Amy Beth | Officer - SVP, Human Resources | SELL | $26.83 | 19,341 | $518,958 | 72,427 | -21.1% |
| 2022-10-20 01:14 | 2022-10-18 | Davidoff Michael J. | Officer - SVP, Payer Business | SELL | $25.26 | 1,075 | $27,155 | 106,114 | -1.0% |
| 2022-09-19 23:39 | 2022-09-16 | Davidoff Michael J. | Officer - SVP, Payer Business | SELL | $27.60 | 1,296 | $35,773 | 108,312 | -1.2% |
| 2022-09-19 23:39 | 2022-09-15 | Hoffman Allison C | Officer - General Counsel & Secretary | SELL | $28.58 | 1,290 | $36,866 | 107,300 | -1.2% |
| 2022-07-25 23:11 | 2022-07-21 | Davidoff Michael J. | Officer - SVP, Payer Business | SELL | $25.00 | 1,404 | $35,100 | 108,312 | -1.3% |
| 2022-07-13 23:08 | 2022-07-11 | Munson Gillian | Director | SELL | $25.59 | 2,605 | $66,656 | 21,550 | -10.8% |
How to Interpret $PHR Trades
Not every insider transaction in Phreesia, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $PHR shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for PHR
Insider activity data for Phreesia, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $PHR, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.